Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw Acquires 8,788 Shares

Retractable Technologies, Inc. (NYSE:RVPGet Free Report) CEO Thomas J. Shaw bought 8,788 shares of the stock in a transaction dated Friday, July 5th. The shares were purchased at an average cost of $1.14 per share, for a total transaction of $10,018.32. Following the completion of the purchase, the chief executive officer now owns 14,521,005 shares in the company, valued at $16,553,945.70. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Retractable Technologies Price Performance

RVP opened at $1.16 on Thursday. Retractable Technologies, Inc. has a twelve month low of $0.87 and a twelve month high of $1.34. The company has a quick ratio of 8.18, a current ratio of 11.02 and a debt-to-equity ratio of 0.01. The company has a 50-day moving average price of $1.08 and a 200 day moving average price of $1.14. The company has a market cap of $34.73 million, a PE ratio of -4.46 and a beta of 2.08.

Retractable Technologies (NYSE:RVPGet Free Report) last released its quarterly earnings results on Wednesday, May 15th. The company reported $0.01 earnings per share for the quarter. Retractable Technologies had a negative net margin of 18.84% and a negative return on equity of 7.55%. The firm had revenue of $7.60 million during the quarter.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on shares of Retractable Technologies in a research note on Saturday, July 6th. They set a “hold” rating on the stock.

Get Our Latest Stock Analysis on RVP

About Retractable Technologies

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Featured Stories

Insider Buying and Selling by Quarter for Retractable Technologies (NYSE:RVP)

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.